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Prevalence of Brucella infection in India
State Prevalence Author
Throughout the country 2% Isloor et al. 1998
Throughout the country 4% Renukaradhya et al. 2002
Punjab 21% Ul-Islam et al. 2013
Assam 13% Gogoi et al. 2017
Gujarat 12% M. D. Patel et al. 2014
Bihar 12% Pandian et al. 2015
Andhra Pradesh 12% Trangadia et al. 2012
Sample collected from 
suspected animals from 
different parts of the country
20-60% Dalvi et al. 2007; Aulakh et al. 2008; 
S.P et al. 2011; Jagapur et al. 2013; Ul-
Islam et al. 2013; Neha et al. 2014; 
Patel et al. 2014; Shome et al. 2015; 
Pathak et al. 2016
ILRI-ICAR study in Bihar 0.5%
ILRI-ICAR study in Assam
Prevalence
• Only 4 outbreaks of brucellosis in cattle and buffalo reported 
with 46 cases in 2016 (Annual Report, DAHDF, 2017)
Gap/limitations
• Many studies in India have not clearly mentioned the 
sampling frame
• Large scale studies on pure random sampling is required to 
report true prevalence
• Sero-positivity does not necessarily mean animals have 
current or active infection; more confirmatory studies are 
required
• Apart from probabilistic method, appropriate sample size, 
use of appropriate diagnostic test and sound laboratory 
methods are essential
Distribution of prevalence studies 
(tentative)
High: Punjab, UP, Karnataka, Gujarat, Maharashtra,…..
Medium: Tamilnadu, Karnataka, Assam, MP,  Haryana, …
Low: Bihar, Odisha, West Bengal,  Jharkhand, Chhattisgarh, north 
eastern states (except Assam), Himalayan states, ……..
Gap/limitation: 
• Priority may be given to the areas where there is lesser 
studies
Risk factors
• Risk factors may be classified in 4 groups
Risk 
factors
Host factor: Age, sex, 
breed, status of 
pregnancy, history of 
abortion, repeat breeding, 
retention of placenta etc.





climate, presence of 
susceptible wildlife etc.
Management factor: 
Herd size, single/mixed 
herd, farming system, 
introduction of new 
animal, distance from 
one farm to another, farm 
Risk factors
Risk factors Host factor
Species Cattle are more likely to be sero-positive than buffalo (Kumar et al. 2016)
Age of animal Older animals are more likely to be sero-positive than calves (Mugizi et al. 2015)
Sex Female dairy animals are more likely to be sero-positive than male (Ul-Islam et al. 2013)
Breed Purebred animals are more likely to be sero-positive than 
indigenous
(Shomeet al. 2014)
History of abortion History of abortion is positively associated with sero-positivity (Lindahl et al. 2014)
History of repeat 
breeding 
History of repeat breeding is positively associated with sero-
positivity 
(Dalviet al. 2007)
History of retention of 
placenta 
History of retention of placenta is positively associated with sero-
positivity 
(Aulakh et al. 2008)
History of metritis/ 
endometritis
History of metritis/ endometritis is positively associated with sero-
positivity 
(Patel et al. 2014)
Farming system Organized farms are positively associated with sero-positivity, 
compared to unorganised
(Kumar et al. 2016)
Mixed herd Cattle being housed with goat and/or sheep are more likely to be  
sero-positive
(Calistri et al. 2013)
Herd size Larger herds are  positively associated with sero-positivity, 
compared to smaller herds
(Mugizi et al. 2015)
Distance between 
herds/ density of herds
Herds located close to one another are positively associated with 
sero-positivity than located away from each other
(Soomro et al. 2014)
Breeding method Breeding by artificial insemination is positively co-related with 
sero-positivity, compared to natural mating
(Shome et al. 2014)
Risk factors
Gap/limitations
• Contradictory risk factors are also reported by some studies
• Identification of risk factors requires adequate sample size 
and ability to accurately measure true disease status. 
• Confounding factors may mask the actual association or 
falsely demonstrate an apparent association between the 
treatment and outcome.
• Establishing actual cause effect relationship is difficult without 
confirmatory diagnosis
Disease economics
• Terminologies like economic impact, loss, and cost of 
brucellosis are used by some researchers loosely and inter-
changeably
• Reduced milk yield (10%)  cause an economic loss of INR 
2,774 per cow and INR 3,015 per buffalo cow (Panchasara
2012). 
• Average costs of treatment following abortion, repeat 
breeding and retention of placenta of dairy cattle were 
estimated at INR 250, INR 320 & INR 506 (Panchasara 2012).  
• Brucellosis cause 20-25% loss of milk production (Bano & 
Ahmad Lone 2015) 
• Abortion caused a loss of INR 5,908  per animal (Dhand et al. 
2005).  
Disease economics (cont…)
• Brucellosis caused a median loss of USD 3.4 (INR 228) billion 
to the livestock sector of which 96% was in the dairy sector 
(Singh et al. 2015)
• Brucellosis caused an economic loss of USD 58.8 million per 






Milk yield loss 16047
Treatment loss 2975
Distress selling loss 19,375
Loss of a calf (average of male & female 
calf price)
3750
Loss caused by repeat breeding 515
Death of cow/heifer 0
Preliminary findings of ongoing ILRI-ICAR research project
Disease economics (cont….)
Gap
• There is paucity of comprehensive economic studies on 
impact of brucellosis in India
• No study has been observed on the economics of brucellosis 
control programme in India
• Different studies use different parameters and approaches         
for working out the economic impact, cost, and loss, therefore  
the estimates varies widely
• Difficult to extrapolate the prevalence data as sero-prevalence 
does not mean occurrence of the disease or loss. 
• More systematic economics studies and approach are 
required to assess the economic impact, loss and cost of 
brucellosis
Human brucellosis
• Brucellosis has been  reported as a major cause of pyrexia of 
unknown origin (PUO). 
• In India, the disease is reported sporadically but the true 
incidence is estimated to be much higher than reported 
because of misdiagnosis and under reporting (Boral et al. 
2009). 
• Sen et al. (2002) found 6.8% sero-positive cases among the 
patients with PUO.
• Pathak et.al (2014) also found 6% sero-prevalence among 
patients with PUO.
Human brucellosis (cont…)
• Higher sero-positivity rate (27 %) was recorded in Ludhiana in 
a purposively sampled population (Yohannes and Sing 2011) .
• 0.8% prevalence reported among a larger group of PUO 
patients (Kadri, 2000)  
• History of ingestion of raw milk (87%), occupational contact 
with animals (81%) & handling of infected materials (62%) 
were reported as the major risk factors (Kochar et al. 2007)
• Among the occupational groups, veterinarians were the most  
affected followed by farm workers (Yohannes et al. 2011)
Gap:
• No study has been observed in randomly selected general 
population 
Knowledge, attitude and practices (KAP)
• ILRI-ICAR study on KAP in Bihar, India suggest the following:
Gap: Dearth of studies on KAP in India
Control 
• Brucella abortus S19 is the most widely used vaccine in the 
world
• B. abortus RB51 vaccine has proved safe and effective against 
bovine brucellosis & exhibits negligible interference with 
diagnostic serology
• Both Brucella S19 and RB51 vaccines are recommended by 
OIE
• A study in UP found that periodic testing of all animals and 
segregation of sero-positive animals reduces seropositive 
from 12.4% to 1.2% (Kollannur et al. 2007). 
• Another study in Punjab found, B. abortus S19 vaccine 
reduced the rate of abortion from 8% to 1% in cows and from 
3% to 1% in buffalo (Gill et al. n.d.)
Contol (cont…)
• Safe and effective vaccines against human, pig and wildlife 
brucellosis are not generally available (Godfroid et al. 2010)
Gap:
• Needs more action research projects on brucellosis control in 
field condition keeping in view the prevailing challenges in 
India
• More effort is required to produce safer and effective 
vaccines (e.g. effective in all age groups, thermostable, not 
interrupting in diagnostic serology etc.)
• Technological intervention may not be good enough without 
building knowledge & capacity of stakeholders
Conclusion
• Plenty of epidemiological studies have been conducted in 
India on brucellosis, many are repetitive in nature.
• Prevalence data has important bearing on milk trade and 
investment on control programme, so assessing true 
prevalence is critical
• In some part of India, epidemiological studies are relatively 
fewer; there is need to prioritize
• Needs well accepted, economically acceptable model for 
assessing disease economics. 
• Customized knowledge products should be designed & 
implemented for the target groups
• More research may be initiated on developing a more 
effective vaccine for the Indian context
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